Should clinical trials about prostate cancer assess the frailty as an endpoint?

被引：0
|
作者：
Irfan Karahan
Didem Sener Dede
机构：
[1] Ankara Bilkent City Hospital,Department of Medical Oncology
[2] Ankara Yildirim Beyazıt University,undefined
来源：
International Urology and Nephrology | 2023年 / 55卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1729 / 1730
页数：1
相关论文
共 50 条
  • [1] Should clinical trials about prostate cancer assess the frailty as an endpoint?
    Karahan, Irfan
    Dede, Didem Sener
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (07) : 1729 - 1730
  • [2] Quality of life as an endpoint for clinical trials of prostate cancer
    Tannock, I
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 55
  • [3] Perceptions about cancer clinical trials among prostate cancer survivors.
    Buzaglo, Joanne S.
    Miller, Melissa F.
    McManus, Shauna
    Johnson, Jamese
    Zaleta, Alexandra Katherine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [4] Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
    Mota, Jose Mauricio
    Armstrong, Andrew J.
    Larson, Steven M.
    Fox, Josef J.
    Morris, Michael J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 522 - 530
  • [5] Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
    Jose Mauricio Mota
    Andrew J. Armstrong
    Steven M. Larson
    Josef J. Fox
    Michael J. Morris
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 522 - 530
  • [6] Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials
    Trock, BJ
    UROLOGY, 2001, 57 (4A) : 241 - 247
  • [7] Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
    Naito, Tateaki
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2019, 6 (03) : 227 - +
  • [8] Clinical trials in prostate cancer
    Schellhammer, P
    BJU INTERNATIONAL, 2003, 92 (03) : 186 - U8
  • [9] Why We should Assess Patients' Expectations in Clinical Trials
    Frisaldi, Elisa
    Shaibani, Aziz
    Benedetti, Fabrizio
    PAIN AND THERAPY, 2017, 6 (01) : 107 - 110
  • [10] Overall survival should be the primary endpoint in clinical trials for advanced non-small-cell lung cancer
    Cheema, P. K.
    Burkes, R. L.
    CURRENT ONCOLOGY, 2013, 20 (02) : E150 - E160
12345